APOE and Alzheimer disease: When compared to age‐matched non‐carrier women with AD, the AD APOE ε4 carriers had decreased platelet cytochrome oxidase (COX) and citrate synthase (CS) enzyme maximum velocities (Vmax) (Wilkins et al., 2017).